Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Burkholderia Infections Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Burkholderia infections are caused by Burkholderia cepacia. It is a gram negative bacillus found in aquatic environment. It is a low virulent bacteria and is a frequent colonizer of fluids used in the hospitals such as IV fluid, irrigation solution etc. B

Coherent Market Insights
Vasculitis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

A group of disorder caused by the inflammation of blood vessels is known as vasculitis (plural: vasculitides), also called angiitis. Vasculitis includes inflammation of arteries, veins, and/or capillaries. The disease can affect both males and females equally without

Coherent Market Insights
Prescription Narcotic Cough Preparations and Expectorants Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Narcotic preparations are medicines that primarily induce sleep. The basic three narcotics are morphine, codeine, and thebaine. Mucokinetics are drugs that clear mucus from the lungs, airways, trachea, and bronchi. Mucokinetics can be divided into expectorants, mucoly

Coherent Market Insights
Gastritis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be acute or chronic. The disease may show some symptoms or the symptoms may be dormant. Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis ma

Coherent Market Insights
Cryptococcosis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though

Coherent Market Insights
Cholestasis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

The liver plays a pivotal role in control of a variety of aspects of lipid metabolism. Principally, the liver synthesizes bile, ingredients of which are necessary for fat absorption in the intestine. Moreover, biliary discharge of cholesterol and phospholipids into th

Coherent Market Insights
Gonorrhea Diagnostic Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Ease of Testing: Can be done on non-invasive and self-collected specimens Sexually transmitted Diseases (STDs) are one of the leading health problems globally, affecting the quality of life and triggering serious m

Coherent Market Insights
Peanut Allergy Vaccine Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some ca

Coherent Market Insights
Dermal Regeneration Template Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Dermal Regeneration Template Market Overview: Dermal regeneration template is a two-layered skin regeneration system. The outer layer of dermal regeneration template is made of thin silicone film act as the epiderm

Coherent Market Insights
Antidiabetic Biosimilars Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Antidiabetic biosimilars market overview Antidiabetics help control blood glucose levels in diabetic patients. Various types of antidiabetics include biguanides, thiazolidinediones, DPP-IV inhibitors, α-gluco

Coherent Market Insights
Antacid Medications Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Antacid Medications Market Overview Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn, which is a major symptom of gastroesophage

Coherent Market Insights
Animal Depression Medication Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016 – 2024

To Be Published : Mar 2018

Animal Depression Medication Market Overview Emotions may be described as subjective, conscious experiences characterized by psychophysiological expressions, mental states, and biological reactions. Several tests such as cognitive bias test and leaned helplessness models

Coherent Market Insights
Shingles Vaccine Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases ch

Coherent Market Insights
Residential Intellectual Disability Facilities Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Residential Intellectual and Developmental Disability Facilities Intellectual disability refers to people who have been classified by one or more terms such as developmental disability, developmental delay and ment

Coherent Market Insights
Refractory Glaucoma Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Globally, Glaucoma is on rise. According to the Glaucoma research Foundation, Glaucoma is the leading cause of irreversible blindness globally. Nearly 10% of the glaucoma patients who receive proper treatment still experience a loss of vision. Around 64.3 million peop

Coherent Market Insights
Nuclear Medicine/Radiopharmaceuticals Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Nuclear Medicine/Radiopharmaceuticals Market Overview Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilitie

Coherent Market Insights
Peyronie’s Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. This condition can cause painful erections and the penis gets bent while it is erected. The bent is towards the side where

Coherent Market Insights
Neuropeptide Y Acetate Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

To Be Published : Mar 2018

Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.